We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
IBCA's newsletter that was circulated on 23 August 2024.
IBCA's newsletter that was circulated on 16 August 2024.
IBCA's newsletter that was circulated on 14 August 2024
Legislation has been laid in Parliament to ban xylazine and 21 other dangerous drugs.
Following a thorough review, the Medicines and Healthcare products Regulatory Agency (MHRA) has concluded that the available evidence does not establish a causal relationship between Glucagon-Like Peptide-1 (GLP-1) receptor …
Letter from the Independent Reconfiguration Panel Chair, Professor Sir Norman Williams, to the Rt Hon the Lord Darzi of Denham OM KBE
The statement explains why NHS England is adopting the Cyber Assessment Framework and moving away from the NDG 10 data security standards as the assessment mechanism for the NHS Data Security and Protection Toolkit.
As the new school year looms, the MHRA sets out key advice on children's medicines and medical devices.
The MHRA has approved an adapted Moderna COVID-19 vaccine (Spikevax) that targets the JN.1 COVID-19 subvariant.
More than 130,000 people across the country will be better protected from diseases such as heart disease, kidney disease and diabetes.
Dr Junaid Bajwa, Professor Graham Cooke, Dr Paul Goldsmith and Rajakumari Long have had their appointments as Non-Executive Directors (NEDs) of the Medicines and Healthcare products Regulatory Agency extended from 1 Sept…
The measles vaccination is part of the NHS Routine Childhood Immunisation Programme – with 1 dose offered at 1 year and a second dose at 3 years 4 months.
World-first public-private collaboration launched to kickstart economic growth and build an NHS fit for the future.
The Government has made the regulations to establish the Infected Blood Compensation Scheme.
GAD works closely with NHS Resolution which handles negligence claims on behalf of indemnity scheme members; NHS organisations and independent sector providers.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 22 August 2024, approved a product licence for the medicine lecanemab (Leqembi) for use in the early stages of Alzheimer’s disease, following a thorou…
Crown Commercial Service agrees to fund two key initiatives to boost commercial capability across NHS.
Temporary ban on prescription and supply of puberty blockers extended.
The UK Health Security Agency is encouraging students to make the healthiest start to their studies possible.
A statement from Sir Robert Francis KC about his recommendations to the government on the proposed infected blood compensation scheme.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).